MOSCOW (Reuters) - The Belarusian health ministry has registered Russia's Sputnik V vaccine, becoming the first country outside Russia to do so, Russia's RDIF sovereign wealth fund said on Monday.
Belarus, a close ally of Russia, began conducting clinical trials using the vaccine on volunteers on Oct. 1 and also reviewed data received during Russia's Phase III clinical trials, the Russian Direct Investment Fund said.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!